Ottawa, Sept. 19, 2024 (GLOBE NEWSWIRE) — The global aseptic sampling market size was valued at USD 0.95 billion in 2023 and is predicted to hit around USD 2.11 billion by 2033, a study published by Towards Healthcare a sister firm of Precedence Statistics.
Download a sample version of this report @ https://www.towardshealthcare.com/personalized-scope/5213
Major Key Insights of the Aseptic Sampling Market
- North America dominated the market share by 38.2% in 2023.
- Asia Pacific is expected to grow at the fastest rate during the forecast period.
- By type, the manual aseptic sampling segment accounted for the largest aseptic sampling market share in 2023.
- By technique, the in-line sampling technique segment dominated the market in 2023.
- By application, the downstream processing segment held the dominant share of the market and is estimated to grow at the fastest CAGR during the forecast period.
- By end-use, the pharmaceutical & biotechnology companies segment held the largest share of the aseptic sampling market in 2023.
Aseptic Sampling Market: A Sterility Imperative
The aseptic sampling market refers to the industry that provides the tools, equipment and systems used for this sterile sampling process. With the increasing focus on product safety and regulatory compliance, the demand for aseptic sampling has been rising. This market serves industries such as pharmaceuticals, biotechnology, and food & beverages, where maintaining sterility during production is critical. The growth of this market is driven by the need for better quality control, advancements in aseptic techniques, and the rising demand for safe, contamination-free products.
Top Companies in the Aseptic Sampling Market
- Danaher Corporation
- Syntegon
- W. L. Gore & Associates
- Merck KGaA
- SIG
- Sartorius AG
- Eppendroff
- GEA Group
- KEOFITT A/S
- Lonza Group
- Thermo Fisher Scientific
- Qualitru Sampling Systems
Get the latest insights on healthcare industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership
| Company Name | Argonaut Manufacturing Services |
| Headquarters | Manufacturer in Carlsbad, California, North America |
| Development | In March 2024, Argonaut Manufacturing Services, a company that helps make drugs for the biopharma and life sciences industries, got $45 million to expand its operations in Carlsbad, CA. They’re building a new facility with better equipment that can fill drug products faster. This will help them make more drugs for both research and selling. They plan to finish setting up everything by 2025. |
| Company Name | Syntegon |
| Headquarters | Waiblingen, Germany, Europe |
| Development | In June 2024, the food, medtech, and pharmaceutical sectors rely on Syntegon for processing and packaging solutions. The business has presented its most recent innovation. A proprietary Settle Plate Changer (SPC) for automatic viability monitoring in the aseptic filling procedure is the latest innovation. Syntegon will assist clients in adhering to the most recent Annex 1 for both new and old equipment with this creative approach. |
Driver
Rising Demand for Pharmaceuticals is Driving the Growth
In the healthcare sector there is a growing demand for biopharmaceuticals, which has emerged as a key factor driving the global aseptic sampling market. Biopharmaceuticals which include vaccines, therapeutic proteins and monoclonal antibodies have become increasingly important in the treatment of wide range of chronic and acute diseases. To ensure the safety and efficacy of these products, they must be developed and manufactured under strict quality control measures, in this process aseptic sampling plays a crucial role.
There is growing need for vaccines and other biopharmaceuticals which require is aseptic environments to avoid contamination, was the reason for this growing need. For instance, the biopharmaceutical sector has seen rapid advancements which are contributing significantly to the rise of aseptic sampling practices.
- In 2021, Pfizer announced a USD 2 billion investment in expanding its manufacturing capabilities for biopharmaceuticals including vaccines. This expansion involved adopting cutting edge aseptic techniques to meet the rising global demand 4 biologics and vaccines which is also furthering boosting the market for aseptic sampling.
Restraint
High-Cost Limit Aseptic Sampling Market Adoption
The high initial investment required for adopting aseptic sampling technologies is one of the key restraints in the global aseptic sampling market. For smaller biopharmaceutical companies and research institutions this challenge is especially significant, as these smaller companies operate with limited budgets. Advanced aseptic sampling systems, excluding automated and single use technologies, offer numerous long-term advantages such as enhanced efficiency, reduced risk of contamination and adherence to regulatory standards. But the upfront costs of implementing these systems can be a significant barrier.
Opportunity
Pharma-Biotech Growth Drives Aseptic Sampling
The growth of the aseptic sampling market is closely related to the expansion of pharmaceutical and biotechnology sectors in developing countries. As pharmaceutical and biotic companies continue to grow in these developed regions, the demand for aseptic sampling technology is rising. As major global players expand their operations in developing countries, the local companies also emerge and contribute significantly to the market’s growth, which creates a valuable opportunity for aseptic sampling solution providers to tap into new markets and meet the increasing demand for sterility and quality control in drug development and manufacturing.
In August of 2023 Brazil’s ANVISA (National Health Surveillance Agency) announced updated regulatory standards for biopharmaceutical manufacturing, emphasizing stricter is septic conditions for drug production. This regulatory shift has promoted local biotech companies to invest in a pic sampling system to ensure compliance and maintain product integrity.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Manual Aseptic Sampling Accounted for the Largest Share
The manual aseptic sampling segment dominated the aseptic sampling market by type in 2023 and the automated manual aseptic sampling segment is anticipated to grow at the fastest CAGR during the forecast time. Extensive use of manual systems in biopharmaceutical manufacturing is the key reason for this dominance. These companies rely on human intervention for precise control and monitoring. Manual aseptic sampling is particularly favored in smaller production batches and laboratories that require flexibility. Despite the rising advancements in automated technologies many companies still prefer manual methods due to their cost effectiveness and the ability to adapt to different processes.
Smaller biopharma corporations often opt for manual aspect sampling as it offers a reliable way to ensure sterility without the need for a large upfront investment in automation.
In-line Sampling Technique Segment Dominated the Market
The in-line sampling technique segment dominated the aseptic sampling market my technique in 2023, and on-line sampling techniques segment is expected to grow at the fastest rate during the upcoming period. The in-line sampling technique can provide real time sampling without interrupting the production process which is the reason of this dominance. In-line sampling allows manufacturers to collect sterile samples directly from the process stream, ensuring accurate quality control and reducing contamination risk. In pharmaceutical and biotech sectors this technique is widely used, where ensuring product quality at various stages of production is critical.
Downstream Processing Segment Held the Dominant Share
By application, the downstream processing segment held the dominant share of the market in 2023 and is estimated to grow at the fastest CAGR during the forecast period. The downstream processing segment has a critical role in the purification and quality control stages of biopharmaceutical manufacturing which is driving the growth of this segment. In downstream processing, aseptic sampling ensures that contaminants are kept out while monitoring the quality and sterility of the product.
The demand for Downstream processing has surged in recent years especially with the rise of biologics and biosimilars. In 2023 companies like Pfizer and Amgen significantly invested in downstream processing technologies for their new biologics production which highlights the importance of aseptic sampling in the market.
Pharmaceutical & Biotechnology Companies Dominated
The pharmaceutical and biotechnology company segment held the largest share of the aseptic sampling market in 2023 by end-use, while the CMOs and CROs segment is estimated to register the fastest growth. This is largely due to the increasing demand for biopharmaceuticals such as vaccines, antibodies and cell therapies, which would require stringent quality control measures. Pharmaceutical companies are expanding their production capacities globally, leading to a higher demand for aseptic sampling to maintain sterility throughout the manufacturing process. Companies like Moderna and BioNTech ramped up their aseptic sampling procedures in 2022 as this killed their vaccine production l illustrating the growing need for these solutions in the industry.
Customize this study as per your requirement @ https://www.towardshealthcare.com/customization/5213
North America Dominated the Market in 2023
North America dominated the aseptic sampling market in 2023. The region has major pharmaceutical and biotechnology companies, particularly in the United States and Canada which is the primary reason of this growth. Companies like Johnson and Johnson, Pfizer and Amgen have been investing heavily in E septic sampling technologies as part of their effort to maintain strict quality control standards especially in vaccine production and other critical therapies.
For instance, in 2022 the US Department of Energy (DOE) announced a funding grant of approximately USD 178 million to promote biotechnology and biomanufacturing research. This funding was aimed at enhancing the production capabilities of biopharmaceuticals through innovations in aseptic sampling and related technologies.
- In Canada, in the biotech industry there is also a notable rise with over USD 25 billion invested in more than 175 Canadian biotech companies since 2019.
- In 2023 Canadian companies like Bellus Health and Chinook Therapeutics attracted significant investments further blustering N America’s position as the dominant player in the global market for aseptic sampling.
Aseptic Sampling Market, North Americas Dominance:
| Region | Market Share (2023) | Recent Developments (2023) | Key Players | Growth Drivers | |
| North America | 38.2 | % |
|
Pfizer, Jhonson & Johnson, Amgen, AbbVie Gilead Sciences |
|
| Asia Pacific | Fastest growing region |
|
Beigene, Sun Pharma, Dr. Reddy’s, Takeda, Samsung Biologics |
|
|
Asia Pacific is on to Grow the fastest Rate During Forecast Period
The region of Asia Pacific currently leads the market and is projected to grow at the fastest rate during the forecast period. Countries like China, India, South Korea and Japan are the key countries during this growth, these countries have seen substantial expansion in their pharmaceutical and biotechnology industries. The Chinese government have taken lots of initiatives which are focused heavily on boosting home grown biotech research which makes it a critical hub for pharmaceutical development.
For example, BeiGene Is one of the chinas largest biopharma company which invested USD 1.8 billion in research and development in 2023. The company’s aggressive research and development strategy supported by national policies has helped to push China to the forefront of biotech innovation.
India is also the major contributor to Asia Pacific growth and is recognized globally for its production of affordable vaccines and generic medications. The Indian Pharmaceutical industry plays a crucial role in supplying cost effective drugs to the world with the country being home to the largest number of US FDA approved pharmaceutical facilities outside the United States. In 2021-2022 India’s pharmaceutical exports reached USD 23.5 billion which highlights its growing presence in the global market.
Browse More Insights of Towards Healthcare:
- The single-use bioprocessing market size to grow from USD 20.96 billion in 2022 at 15.46% CAGR (2023-2032) to reach USD 84.14 billion by 2032.
- In 2023, the global multiplex detection immunoassay market was valued at $2.58 billion, and it’s expected to reach $7.81 billion by 2034, growing at a steady annual rate of 9.75% over the next decade.
- The global healthcare facility management market was worth $288.9 billion in 2023 and is forecasted to rise significantly to $870.75 billion by 2034, with an annual growth rate of 10.55%.
- The global automated cell counting market, valued at $3.98 billion in 2023, is projected to surge to $14.51 billion by 2034, growing at a strong annual rate of 12.48%.
- The in vitro lung model market, which was valued at $312 million in 2023, is set to expand rapidly, reaching $1.65 billion by 2034, at an impressive growth rate of 17.7% per year.
- The global rat and mouse model market was valued at $1.46 billion in 2023 and is expected to grow to $3.10 billion by 2034, with a more moderate annual growth rate of 7.1%.
- The global microRNA market was valued at $1.61 billion in 2023 and is projected to grow to $6.11 billion by 2034, with an annual growth rate of 12.89%.
- The global biological safety testing products and services market, valued at $4.9 billion in 2023, is expected to grow to $15.07 billion by 2034, at an annual growth rate of 10.75%.
- The global gRNA (guide RNA) market, valued at $499.21 million in 2023, is forecasted to grow rapidly, reaching $3.30 billion by 2034, with an impressive annual growth rate of 18.72%.
- The global cell therapy human raw materials market was valued at $2.91 billion in 2023 and is projected to reach $22.75 billion by 2034, growing at a strong annual rate of 22.38%.
Segments Covered in the Report
By Type
- Manual Aseptic Sampling
- Valves
- Bags
- Bottles
- Other Accessories
- Automated Aseptic Sampling
By Technique
- In-line Sampling Technique
- On-line Sampling Technique
- Off-line Sampling Technique
By Application
- Downstream Processing
- Upstream Processing
By End-use
- Pharmaceutical & Biotechnology Companies
- CMOs & CROs
- Others
By Region
- North America
- U.S.
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Thailands
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East and Africa (MEA)
- South Africa
- UAE
- Saudi Arabia
- Kuwait
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/aseptic-sampling-market-sizing
Acquire our comprehensive analysis today @ https://www.towardshealthcare.com/price/5213
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership. Stay updated on healthcare industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the curve with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Browse our Brand-New Journals:
https://www.towardspackaging.com
https://www.towardsautomotive.com
https://www.precedenceresearch.com
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
Get Our Freshly Printed Chronicle: https://www.healthcarewebwire.com
COMTEX_457922211/2471/2024-09-19T11:00:34